Inicio>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>Lenalidomide-C5-amido-Boc

Lenalidomide-C5-amido-Boc

Catalog No.GC63474

Lenalidomide-C5-amido-Boc es el ligando de Cereblon basado en lenalidomida que se utiliza en el reclutamiento de la proteÍna CRBN. La lenalidomida-C5-amido-Boc se puede conectar al ligando de la proteÍna mediante un enlazador para formar PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

Lenalidomide-C5-amido-Boc Chemical Structure

Cas No.: 2138441-25-3

Tamaño Precio Disponibilidad Cantidad
100 mg
261,00 $
Disponible
500 mg
792,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Lenalidomide-C5-amido-Boc is the Lenalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Lenalidomide-C5-amido-Boc can be connected to the ligand for protein by a linker to form PROTAC[1].

[1]. Wang, Shaomeng, et al. Preparation of phthalimide-based compounds as monofunctional intermediates for ligand-dependent target protein degradation. World Intellectual Property Organization, WO2017176958 A1 2017-10-12.
[2]. Robbins, Daniel, et al. WBifunctional compounds for degrading BTK via ubiquitin proteasome pathway. World Intellectual Property Organization, WO2021091575 A1 2021-05-14.

Reseñas

Review for Lenalidomide-C5-amido-Boc

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lenalidomide-C5-amido-Boc

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.